Related Experiment Video

Updated: Jun 22, 2026

Preparation Of Neovascular Tissues from Human Glioma Tissues for Quantitative Proteomics Analysis of Tumor Angiogenesis
09:33

Preparation Of Neovascular Tissues from Human Glioma Tissues for Quantitative Proteomics Analysis of Tumor Angiogenesis

Published on: March 20, 2026

[Prospects for targeted therapy for gliomas]

V P Chekhonin, V P Baklaushev, G M Iusubalieva

    Vestnik Rossiiskoi Akademii Meditsinskikh Nauk
    |June 12, 2009
    PubMed

    Insights

    This review explores advanced radioimmune therapy and targeted treatments for high-grade gliomas. Promising techniques include monoclonal antibodies, signaling pathway inactivation, and nanoparticle delivery systems.

    Area of Science:

    • Oncology
    • Immunotherapy
    • Nanotechnology

    Context:

    • High-grade gliomas represent aggressive brain tumors with limited treatment options.
    • Targeted therapies aim to improve treatment efficacy and reduce systemic toxicity.

    Purpose:

    • To review current and emerging targeted treatment strategies for high-grade gliomas.
    • To analyze the potential of radioimmune therapy and novel approaches.

    Summary:

    • Radioimmune therapy utilizes monoclonal antibodies targeting tumor-specific antigens like nucleoproteins, matrix proteins, and growth factor receptors.
    • Emerging techniques include inactivating critical signaling pathways, boron neutron capture therapy, and employing biomimetic protein vectors for targeted nanoparticle delivery.

    Impact:

    • This review provides insights into innovative therapeutic avenues for high-grade gliomas.
    • It highlights the potential of precision medicine in neuro-oncology.

    More Related Videos

    Nanoparticle Delivery of an Oligonucleotide Payload in a Glioblastoma Multiforme Animal Model09:02

    Nanoparticle Delivery of an Oligonucleotide Payload in a Glioblastoma Multiforme Animal Model

    Published on: September 27, 2024

    Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts11:15

    Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

    Published on: September 1, 2018

    Related Concept Videos

    Targeted Cancer Therapies02:57

    Targeted Cancer Therapies

    The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
    There are several types of targeted therapies against specific...
    Targeted Cancer Therapies02:57

    Targeted Cancer Therapies

    The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
    There are several types of targeted therapies against specific...